Recent Updates
Recently added Catalysts
SGMT

TVB-2640 with Bevacizumab in Relapsed High-grade Astrocytoma

Wednesday, September 30, 2020 1 min read
Key Takeaway: TVB-2640 with Bevacizumab in Relapsed High-grade Astrocytoma

Full Press Release Details

TVB-2640 with Bevacizumab in Relapsed High-grade Astrocytoma.
Tags: SGMT Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Sep 30, 2020